Model to Predict Coinfection in Elderly Patients With COVID-19

Covid19 Clinical Trial

Official title:

Construction and Validation of a Predictive Model of Coinfections in Elderly COVID-19 Patients After Abandoning Zero Policy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06321367
• Other study ID #: 202401002
• Secondary ID: 8207061382370638
• Status: Completed
• Start date: December 20, 2022
• Est. completion date: June 30, 2023

Study information

• Verified date: March 2024
• Source: Xiangya Hospital of Central South University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The goal of this observational study is to learn about the clinical characteristics and construction of a predictive model in elderly COVID-19 patients. The main question it aims to answer is the main clinical characteristics and risk factors of elderly COVID-19 patients. Participants will not be asked to do any other intervening measure.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: June 30, 2023
• Est. primary completion date: June 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age greater than or equal to 65 years old;

• COVID-19 was diagnosed with SARS-CoV-2 reverse transcription-polymerase chain reaction positive or rapid antigen test positive or a clinical diagnosis made by the radiological responsible clinician based on signs, symptoms, or radiology consistent with COVID-19;

• Hospitalization more than one day, including patients in emergency.

Exclusion Criteria:

• Age less than 65 years old;

• Pregnancy;

• Hospitalization less than one day;

• Outpatients;

• Patients with missing or incomplete information.

Related Conditions & MeSH terms

• Coinfection
• COVID-19
• Covid19

Locations

Country	Name	City	State
China	Xiangya Hospital of Central South University	Changsha	Hunan

Sponsors (1)

Lead Sponsor	Collaborator
Xiangya Hospital of Central South University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Coinfection	The investigators defined coinfection as coinfected bacteria, fungi, or other viruses with SARS-CoV-2 that occurred from admission to 7 days after admission. If a diagnosis was at the time of or within the first 48 hours of COVID-19 hospital admission, these infections were defined as community-acquired infections. If diagnosis occurred =48 hours to 7 days after admission for COVID-19, these infections were defined as early-onset hospital-acquired infections.	from admission to 7 days after admission